Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Major Depressive Disorder Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05271084
What this trial is testing

Pentoxifylline as an Adjunct to Citalopram in Adult Patients With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Hawler Medical University 100
Large-scale testing (Phase 3)Study completedNCT01808651
What this trial is testing

Fluoxetine in Major Depressive Disorder (MDD) Long-Term Dosing

Who this might be right for
Major Depressive Disorder
Eli Lilly and Company 200
Not applicableStudy completedNCT06615804
What this trial is testing

The Effects of Transcranial Magnetic Stimulation on Retina and Choroidal Structures

Who this might be right for
Major Depressive Disorders
Gulhane Training and Research Hospital 58
Large-scale testing (Phase 3)Looking for participantsNCT06372964
What this trial is testing

Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients

Who this might be right for
Bipolar Depression
Intra-Cellular Therapies, Inc. 384
Post-approval studies (Phase 4)Study completedNCT01902004
What this trial is testing

Brain Aging and Treatment Response in Geriatric Depression

Who this might be right for
Mild Cognitive Impairment (MCI)Depression
University of California, Los Angeles 115
Not applicableStudy completedNCT03143075
What this trial is testing

Do Omega-3 Fatty Acids Have an Antidepressant Effect in Patients With Signs of Peripheral Inflammation?

Who this might be right for
Major Depressive Disorder
Region Skane 95
Not applicableStudy completedNCT06165445
What this trial is testing

Optimizing tDCS Protocol for Clinical Use in Major Depressive Disorder

Who this might be right for
Depressive DisorderCognitive ImpairmentPsychiatric Disorder
The National Brain Mapping Laboratory (NBML) 60
Large-scale testing (Phase 3)Study completedNCT00321490
What this trial is testing

Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo and Active Control in Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
AstraZeneca 600
Post-approval studies (Phase 4)Looking for participantsNCT07136714
What this trial is testing

Does Semaglutide Improve Depressive Symptoms in Patients With Major Depressive Disorder and Overweight or Obesity

Who this might be right for
Major Depressive Disorder
Nordsjaellands Hospital 116
Testing effectiveness (Phase 2)Study completedNCT04088448
What this trial is testing

The Antidiabetic Metformin as a Novel Adjunct to Antidepressants in Major Depressive Disorder Patients

Who this might be right for
Major Depressive Disorder
Sadat City University 80
Not applicableStudy completedNCT02309060
What this trial is testing

Storytelling Video Intervention for Depressed Primary Care Patients - Open Trial

Who this might be right for
Major Depressive Disorder
Butler Hospital 11
Not applicableLooking for participantsNCT07540585
What this trial is testing

MOCHA: Embedded Inpatient Mental Health Care for High-Risk Perinatal Patients

Who this might be right for
Anxiety DisordersStress Disorders, Post-TraumaticPregnancy, High Risk+3 more
Indiana University 50
Post-approval studies (Phase 4)Study completedNCT02191124
What this trial is testing

The Measurement-based Care in Patients With Depressive Disorder: A Randomized Controlled Trial

Who this might be right for
Major Depressive Disorder
Capital Medical University 164
Not applicableStudy completedNCT04638231
What this trial is testing

Supportive Text Messaging Versus Supportive E-mail Messaging for Patients With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
University of Alberta 66
Large-scale testing (Phase 3)Study completedNCT00694304
What this trial is testing

Open-label Safety Extension Study of 2.5, 5 and 10 mg of Vortioxetine (Lu AA21004) in Long-term Treatment of Major Depressive Disorder in Adults

Who this might be right for
Major Depressive Disorder
H. Lundbeck A/S 535
Post-approval studies (Phase 4)Study completedNCT01573598
What this trial is testing

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Forest Laboratories 1,219
Early research (Phase 1)Study completedNCT02433093
What this trial is testing

The Safety, Tolerability, and Pharmacokinetics of Multiple-Ascending Dose Basimglurant in Healthy Subjects and in Patients With Major Depressive Disorder (MDD)

Who this might be right for
Major Depressive Disorder, Healthy Volunteer
Hoffmann-La Roche 56
Not applicableStudy completedNCT01975948
What this trial is testing

Evaluation of a Mental Health Physician Support Program in Nova Scotia

Who this might be right for
Major Depressive Disorder
Nova Scotia Health Authority 285
Not applicableLooking for participantsNCT07105397
What this trial is testing

Evaluating Conversational Artificial Intelligence for Depression Management

Who this might be right for
Major Depressive Disorder (MDD)
George Mason University 130
Testing effectiveness (Phase 2)Study completedNCT00048204
What this trial is testing

A New Medicine (GW597599B) For The Treatment Of Major Depressive Disorder

Who this might be right for
Depressive Disorder, Major
GlaxoSmithKline 372
Next Page